Chongyong Xu
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery 1
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 1
-
- Long-Term Effects of COVID-19 2
-
- Cancer-related molecular mechanisms research 2
-
- Dermatological and COVID-19 studies 2
-
- Pancreatic and Hepatic Oncology Research 1
-
- Gastroesophageal reflux and treatments 1
- Co-authors
- Wei ChenKenneth I. ZhengZhihan YanYaping ZhaoYanyan XuCui‐Tao LuYi ZhangZhiguo Feng
- Journals
- International Journal of Medical Sciences (1 paper)International Journal of Pharmaceutics (1 paper)Annals of Clinical Microbiology and Antimicrobials (1 paper)
- Partner nations
- China
In The Last Decade
Chongyong Xu
10 papers receiving 354 citations
Peers
Comparison fields: 5 of 80
- Pharmaceutical Science 65
- Infectious Diseases 173
- Drug Discovery 1
- Neurology 84
- Molecular Medicine 26
Countries citing papers authored by Chongyong Xu
This map shows the geographic impact of Chongyong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongyong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongyong Xu more than expected).
Fields of papers citing papers by Chongyong Xu
This network shows the impact of papers produced by Chongyong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongyong Xu. The network helps show where Chongyong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chongyong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2021 | 4 | |
| 3 | 2021 | 14 | |
| 4 | 2020 | 25 | |
| 5 | 2020 | 208 | |
| 6 | 2020 | 1 | |
| 7 | 2019 | 13 | |
| 8 | 2015 | 8 | |
| 9 | 2013 | 95 | |
| 10 | [Diagnostic value of magnetic resonance imaging in special-site ectopic pregnancy]. | 2013 | 2 |
| 11 | [Study on the diagnostic value of imageology of giant cell tumour of tendon sheath]. | 2008 | 1 |
About Chongyong Xu
Chongyong Xu is a scholar working on Dermatology, Molecular Medicine, Gastroenterology, Pharmaceutical Science and Infectious Diseases, having authored 11 papers that have together received 371 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Cancer-related molecular mechanisms research (2 papers), Long-Term Effects of COVID-19 (2 papers), Dermatological and COVID-19 studies (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Gastroesophageal reflux and treatments (1 paper) and Advancements in Transdermal Drug Delivery (1 paper). The work is most often cited by research in Pharmaceutical Science (65 citations), Infectious Diseases (173 citations), Drug Discovery (1 citation), Neurology (84 citations) and Molecular Medicine (26 citations). Chongyong Xu has collaborated with scholars based in China. Frequent co-authors include Wei Chen, Kenneth I. Zheng, Zhihan Yan, Yaping Zhao, Yanyan Xu, Cui‐Tao Lu, Yi Zhang, Zhiguo Feng, Ying‐Zheng Zhao and Jian Xiao. Their work appears in journals such as International Journal of Medical Sciences, International Journal of Pharmaceutics, Annals of Clinical Microbiology and Antimicrobials, Molecular Therapy — Nucleic Acids and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.